1.
-
May 25, 2020 - recruitment opens
-
June 7, 2020 - deadline for applications
Research projects for admissions 2020/2021-1:
Linking abnormal Ca2+ signaling and the unfolded protein response with Huntington’s disease pathology in both YAC128 mouse model and iPSC-derived neurons from HD patients.
Prof. Jacek Kuźnicki, PhD; Magdalena Czeredys, PhD, Laboratory of Neurodegeneration
Description: Huntington’s disease (HD) is a progressive neurodegenerative disorder characterized by the aggregation of mutant huntingtin and degeneration of medium spiny neurons (MSNs) in the striatum. Abnormal Ca2+ signaling is considered as an early event in HD pathology since disturbances in Ca2+ homeostasis were found in HD models and postmortem samples from HD patients. One of the pathways for Ca2+ signaling is store-operated calcium entry (SOCE). The activation of inositol-(1,4,5)triphosphate receptor 1 (IP3R1) results in Ca2+ release, which decreases ER Ca2+ content and activates Ca2+ influx through SOC channels. Elevated SOCE and increased IP3R1 activity was previously reported in MSNs from the transgenic model of HD, YAC128. The project is based on the hypothesis that neurodegeneration in HD is induced by disturbances in Ca2+ signaling in neurons. Previously we found that huntingtin-associated protein 1 (HAP1) that is overexpressed in striatal neurons and binds to mutant huntingtin causes dysregulation of Ca2+ signaling by increased activation of both SOCE and IP3R1 receptors. We intend to examine the link between dysregulated Ca2+ signals and neuronal cell death in HD. The experiments will be performed in YAC128 MSNs cultures and neurons delivered by the reprogramming of fibroblasts from HD patients with the application on CRISPR/Cas9-based editing strategies and Ca2+ signaling inhibitors.
Aim: The project aims to investigate whether and how the disturbed Ca2+ homeostasis affects HD pathology. A Ph.D. project related to this issue will be done using different HD models. One position is available in the project. We are looking for a person interested in neurobiology, with experience in working with animal models (mice, zebrafish), cell cultures, and biochemical techniques (immunoprecipitation, western blot). Knowledge/experience in iPSCs cultures is welcome.
Number of positions available: 1
Source of funding: NCN/OPUS grant
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
Cytoplasmic polyadenylation as a central regulator of physiological processes
Prof. Andrzej Dziembowski, PhD, Laboratory of RNA Biology
Description: Poly(A) tails generated by canonical poly(A) polymerases during mRNA 3’ formation are essential for mRNA stability and translation. It is now appreciated that poly(A) tail dynamics is more complex than previously suspected; deadenylated mRNAs in the cytoplasm can be degraded, uridylated or stored in a dormant state to be later re adenylated to activate protein synthesis. Cytoplasmic polyadenylation was mostly studied in the context of gametogenesis and in synapses, where the transcriptional activity is limited. Surprisingly, mouse lines devoid of the well known cytoplasmic poly(A) polymerase GLD2 display no apparent phenotypes. We recently described a novel family of cytoplasmic poly(A) polymerases, TENT5 (FAM46), comprising four members in vertebrates (Mroczek et al. & Bilska et al. Nat Comm 2017,2020). TENT5C acts as a tumor suppressor in multiple myeloma, while mutations in TENT5A lead to a rare disease osteogenesis imperfecta. We have generated KO mouse models for all TENT5 genes and detected a variety of different phenotypes affecting several organs and biological processes: gametogenesis, growth, skeletal development, hematopoiesis, immune response, and behavior. Moreover, analysis of the KO of worm TENT5 orthologue revealed dysfunction of innate immunity. Thus, TENT5 proteins contribute significantly to metazoan physiology and, more generally, that cytoplasmic polyadenylation plays a much broader role than previously anticipated, opening a new area of important research.
Aim: The project aims is to dissect functions and mechanisms of cytoplasmic polyadenylation by TENT5 in innate immunity, erythropoiesis, and neuronal physiology. Unique animal models constructed using CRISPR/Cas9, combined with advanced transcriptomic and proteomic approaches, will be used to achieve our goals. Several positions are available in the lab. The exact PhD project will depend on the particular skills and preferences of the student. We are looking for students with experience in work with animal modes (mouse, C. elegans), RNA biology, or bioinformatics.
Number of positions available: 4
Source of funding: NCN/Norway grants/FNP/Horizon2020 era chairs
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
See also:
2.
-
05/08 - recruitment opens
-
18/08 - deadline for applications
-
7/09 – 17/09 - interviews
-
21/09 – publication of results
Research projects for admissions 2020/2021-2:
Title: Elucidating the epigenetic contribution to cardiovascular lineage specification
Supervisor: Cecilia Winata
Institute: International Institute of Molecular and Cell Biology in Warsaw
Laboratory: Laboratory of Zebrafish Developmental Genomics
Background:
One key question in the field of organogenesis relates to how the many types of cells required to make an organ are generated from a pool of progenitor cells with initially similar characteristics. Heart (cardiac) progenitor cells are located close to those that will also generate blood and blood vessels (hemoangiogenic). At very early stages of embryonic development, they express nkx2.5 in common. Subsequently, each type of cells expresses different sets of genes and adopts epigenetic states which signifies their identity. Despite the knowledge that nkx2.5-expressing progenitors could contribute to diverse cell lineage types, several key questions remain unanswered. First, it is unclear at which developmental stage the segregation between cardiac and hemoangiogenic fates begin to occur. Second, the exact pathway and intermediate stages which these progenitors go through during the process of lineage specification are still largely unknown. In addition, despite the knowledge that cardiac transcription factors including Nkx2.5 itself are known to interact with chromatin modifying factors and promote chromatin changes, it is still unknown to what extent epigenetics play a role in driving cell fate decisions at the individual cell level. By tracing the evolution of cellular heterogeneity over time, and at the same time assessing the dynamics of epigenetic landscape at the single cell level, we will elucidate the mechanism of cardiovascular lineage specification.
Aim:
The goal of this project is to elucidate the epigenetic contribution towards the lineage decision of nkx2.5-expressing progenitors into either cardiac or hemoangiogenic lineage. We hypothesize that distinct epigenetic states occur among subpopulations of nkx2.5-expressing progenitors according to their lineage diversification potential. We will profile open chromatin regions at single cell level anddetermine whether Nkx2.5 plays a role in establishing the epigenetic state by scATAC-seq method(Jia et al., 2018,Nat Commun9, 4877).
Requirements:
-
Bachelor’s or Master’s degree in Biology, Biochemistry, or equivalent
-
Solid understanding of the principles of molecular biology and genetics
-
Previous laboratory experience in molecular biology and/or biochemistry techniques
-
Prior experience in flow cytometry, NGS, and/or working with animal models (mouse or zebrafish), as well as basic programming skills would be an advantage although not essential
-
Ability to communicate fluently in English and has a collaborative attitude
Title: Lysine deserts as a universal mechanism to escape premature proteins degradation
Supervisor: dr hab. Wojciech Pokrzywa
Institute: International Institute of Molecular and Cell Biology in Warsaw
Laboratory: Laboratory of Protein Metabolism in Development and Aging
Background:
Eukaryotic cells use degradation systems such as the ubiquitin-proteasome (UPS) system to remove unwanted proteins. UPS mediates proteolysis by attaching the small protein ubiquitin to the target protein, using a cascade of enzymes in a process called ubiquitination. Ubiquitin is attached primarily to a specific amino acid in the target protein - lysine. Recent studies have shown that the yeast protein Slx5 avoids UPS due to the extensive, lysine-free region in the so-called lysine desert. Such a lysine desert may be a part of the uncharacterized strategy used by proteins to avoid premature degradation. As a result of our initial analyzes, we found various lysine deserts among the proteins of both simple and complex organisms. Many of these proteins are associated with the UPS, suggesting a protective mechanism against self-determination for degradation. However, we have also found lysine deserts in proteins involved in fundamental cellular processes such as transcription.
Aim:
The overall objective of these studies is to understand the common occurrence of proteins with lysine deserts using evolutionary and structural bioinformatics analyzes supported by experimental methods. The theoretical part will consist of a quantitative analysis of the evolutionary preservation of lysine deserts in a number of taxonomic groups, followed by a qualitative analysis of their biological functions. Selected proteins will also be analyzed via molecular simulations to understand the dynamics of lysine desert exposure under selected conditions. The most promising candidates obtained from bioinformatics analyzes will be subjected to experimental tests using human cell lines and animal model Caenorhabditis elegans.
Requirements:
-
Master's degree in biological sciences/bioinformatics
-
experience in programming (Python/R), omics data analysis and cluster computing
-
knowledge of biological databases, biochemistry, molecular biology, evolutionary and structural bioinformatics of proteins
-
fluency in English
-
strong motivation for scientific work (documented internships and apprenticeships in scientific institutes)
-
ability to organize working time independently
-
systematic work
-
experience in molecular modeling and/or laboratory work/C. elegans maintenance is an advantage
Title: The impact of cytoplasmic polyadenylation on local translation in neurons
Supervisor: prof. dr hab. Andrzej Dziembowski
Institute: International Institute of Molecular and Cell Biology in Warsaw
Laboratory: Laboratory of RNA Biology
Background:
Neurons communicate with each other through synapses, specialized contact sites that enable electrical impulses to be transmitted between cells. Synapses are small, but partly independent compartments of the neuron because they contain the molecular machinery indispensable for protein synthesis. This process of protein production on the basis of mRNAs transported to distant synapses from the cell body is called local translation. Local protein synthesis is essential for the proper functioning of the synapse, and its dysregulation is the cause of severe neurodevelopmental disorders. In recent years, thanks to the development of new technologies, we have learned more about these essential processes taking place in synapses. However, the precise molecular mechanisms by which synaptic translation is regulated is still far from being understood.
The ends of mRNA molecules are specifically modified in order to enhance their stability and ability to serve as a template for proteins synthesis at ribosomes: at the 5’ end so-called cap structure is positione, while at the end, there is a poly(A) tail. Nearly all mRNAs in the cell are polyadenylated in the nucleus right after being transcribed from DNA and before their transport to the cytoplasm. However, there is growing evidence that the process of polyadenylation can also take place in the cytoplasm and is therefore called cytoplasmic polyadenylation. In neurons, cytoplasmic polyadenylation of synaptic mRNAs plays a significant role in the regulation of protein synthesis. However, until now, it was studied only for a few mRNAs, and the global impact of this phenomenon and the specific enzymes carrying out the reactions are unknown.
This research project will be performed in cooperation with Prof. Clive Bramham from the University of Bergen and Prof. Magdalena Dziembowski from CENT UW.
Aim:
We aim to elucidate the function and mechanism of cytoplasmic polyadenylation of neurons. To achieve our goals, unique animal models constructed using the CRISR/Cas9 method, combined with advanced transcriptomic and proteomic approaches, will be used.
Two positions are available in the laboratory. The exact project will depend on the specific skills and preferences of the student. We are looking for students with experience in working with animal models, RNA biology or bioinformatics.
See also:
3.
-
December 8, 2020 - Recruitment announcement published
-
December 22, 2020 - Start of the recruitment
-
January 5, 2021 - Deadline for documents submission
Research projects for admissions 2020/2021-3:
1. Title: Rac1 contribution to brain connectivity impairments and neuropsychiatric disorders in Tuberous Sclerosis Complex (NCN/OPUS)
Supervisor: Prof. Jacek Jaworski
Auxiliary Supervisor: Justyna Zmorzyńska, PhD
Institute: International Institute of Molecular and Cell Biology in Warsaw
Laboratory: Laboratory of Molecular and Cellular Neurobiologylular Neurobiology
During the brain development specific cellular events, including establishment of neural polarity, axon elongation, and synapse formation, happen in a temporally and spatially controlled manner to establish connectivity. These temporal and spatial boundaries are created by tight regulation of intrinsic and extrinsic factors. One of major components that may perform this regulation during connectivity development is Rac1 as it links plasma membrane receptors with actin dynamics. Also, mammalian target of rapamycin (mTOR) integrates intra- and extracellular factors. The diseases associated with over-expression of mTOR usually exhibit impairments of the brain development and neuropsychiatric phenotypes that do not necessarily correlate with mutation burden or cannot necessarily be explained by levels of mTOR activation. One of the examples is Tuberous Sclerosis Complex (TSC) in which neuropsychiatric disorders like autism spectrum disorder, intellectual disability, or anxiety do not fully correlate with mTOR expression levels, epilepsy, or tumor burden. Therefore, other molecular pathways must interact with mTOR pathway in order to produce these phenotypes. Our results and preliminary data suggest that Rac1 pathway and its diverse inputs may participate in the regulation of neuropsychiatric disorders in TSC through control of connectivity formation during development. The project will be conducted using zebrafish TSC model.
Aim:
The main objective of this project is to unravel how the interplay between various pathways that converge on Rac1 may participate in the brain connectivity and underlie TSC-associated neuropsychiatric disorders. The project will include behavioral testing, extensive microscopy imaging and image analysis, and transcriptome analysis.
Requirements:
-
Master’s degree in Biology, Biochemistry, Bioinformatics, or related area
-
Solid understanding of the principles of molecular and cellular biology; knowledge on brain development, neuroscience, or computer vision will be a plus
-
Willingness to work with zebrafish animal model
-
Previous laboratory experience in basic molecular biology, biochemistry techniques, and/or imaging experience
-
Prior experience in NGS, and/or working with animal models (mouse or zebrafish), as well as basic programming skills would be an advantage although not essential
-
Ability to communicate fluently in English and a collaborative attitude
Number of positions available: 1
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
2. Title: Identification of novel vulnerabilities of VPS4B-deficient cancer cells (NCN/OPUS)
Supervisor: Prof. Marta Miączyńska
Auxilliary Supervisor: Ewelina Szymańska, PhD
Institute: International Institute of Molecular and Cell Biology in Warsaw
Laboratory: Laboratory of Cell Biology
Project description:
One of the key challenges in oncology is to effectively kill cancer cells while leaving healthy cells intact. To meet this goal, precision oncology aims to tailor anti-tumor therapies to individual genetic changes in cancer cells of a given patient. To provide new targets for precision oncology we need to understand the relationship between the genetic alterations of cancer cells and the dependencies (vulnerabilities) they cause.
VPS4A and VPS4B enzymes together with the Endosomal Sorting Complex Required for Transport (ESCRT) machinery are involved in membrane remodeling during e.g. endocytosis, cell division, and plasma membrane repair. In our previous project, we identified VPS4B deficiency as a selective weakness of colorectal cancer cells with chromosome 18q deletion. We also demonstrated that survival of VPS4B-depleted cancer cells depends on the presence of VPS4A and characterized the molecular consequences of simultaneous depletion of VPS4 proteins that lead to cell death (more details in Szymańska et al, EMBO Mol Med, 2020). Very probably, VPS4B deficiency makes cancer cells more vulnerable not only to VPS4A loss but also to other perturbations affecting gene(s) cooperating with VPS4B in cellular processes essential for life.
Aim:
We aim to identify and characterize novel vulnerabilities of VPS4B-deficient cancer cells among candidates selected from datasets of the Cancer Dependency Map Project (Broad Institute). To this end, we will examine the impact of simultaneous depletion of VPS4B and a selected candidate on in vitro and in vivo growth of cancer cells. Further, we will elucidate the consequences of depletion of VPS4B and a candidate for cancer-relevant cellular processes, e.g. endocytosis, cytokinesis and migration.
Requirements:
-
Master's degree in biology, biochemistry or related field.
-
Solid understanding of the principles of cell and molecular biology.
-
Previous experience in laboratory work and familiarity with basic molecular biology techniques.
-
Written and spoken fluency in English.
-
Good interpersonal skills and a collaborative attitude.
Number of positions available: 1
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
3. RNA-Protein Interactions in Human Health and Disease (NCN/DIOSUCRI)
Supervisor: Gracjan Michlewski, PhD, DSc
Institute: International Institute of Molecular and Cell Biology in Warsaw
Laboratory: Laboratory of RNA-Protein Interactions
Project description:
RNA-binding proteins (RBPs) are key molecules that control gene expression through RNA-protein interactions. Consequently, they contribute to cellular homeostasis, normal development and majority of human diseases. Importantly, new RBPs are being discovered by high-throughput proteomics, but we still have a limited understanding of their function.
RNA viruses have caused several epidemics in the 21st century. Taking influenza A virus (IAV) infection as an exemplar, it kills 250,000 to 500,000 people annually and generates a significant global socioeconomic burden. Importantly the emergence of COVID-19 pandemic caused by an RNA virus SARS-CoV-2 continue to have catastrophic consequences on public health and world economy. Thus, a detailed molecular understanding of host-virus interactions is imperative in order to know how best to inactivate these viruses and prevent major disruptions in the future.
We have recently discovered and started characterising novel RNA binding protein – E3 ubiquitin ligase TRIM25 (Choudhury et al. 2014; Choudhury et al. 2017). TRIM25 belongs to a large family of tripartite motif-containing proteins (more than 80), most of which have E3 ubiquitin ligase activity. Many of TIRIMs are positive or negative regulators of innate immune response pathways. Importantly, TRIM25 is emerging as a key factor in the innate immune response to RNA viruses (including IAV, CoV, dengue virus and many others). Despite the essential involvement of TRIM25 in viral RNA-induced innate immunity, its RNA-binding functions are still poorly understood.
Aim:
With this project, we aim to take advantage of an assembled multi-disciplinary team to uncover the roles of the novel RNA-protein interactions in the antiviral response to selected RNA virus infections. We hypothesise that TRIM25 binds directly to viral RNAs to restrict virus propagation. We also hypothesise that other members from TRIM family bind RNA. Finally, we hypothesise that specific host RBPs bind to virus derived RNAs and inhibit or augment innate immune response. In summary, this project has the potential to make crucial contributions to understanding the innate immune response to RNA viruses and provide a platform for the development of novel, RNA-based antiviral therapeutics.
Requirements:
-
MSc degree in biology, biochemistry or related field
-
Solid knowledge of the principles of cell and molecular biology, virology or biochemistry
-
Hands-on experience in laboratory work and is familiar with basic cell and molecular biology techniques
-
Prior experience in virus handling and analysis, cell culture, mass spectrometry or bioinformatics will be an advantage
-
Proficiency in written and spoken English
-
Excellent interpersonal skills, initiative and ability to work independently and in a high-performance team
Number of positions available: 2
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
4. Title: Cellular adaptation to cold (NCN/GRIEG)
Supervisor: Wojciech Pokrzywa, PhD, DSc
Institute: International Institute of Molecular and Cell Biology
Laboratory: Laboratory of Protein Metabolism
Project description:
Environmental stressors can seriously jeopardize animals’ ability to survive and reproduce. One, potentially dangerous, environmental stressor is acute cold. To counteract cold, affected organisms mount various types of responses, ranging from cold avoidance to adaptation.
The latter strategy is used by hibernating animals, which, in extreme cases, can survive subzero temperatures for many days. Here, we propose to utilize a simple animal model, the nematode Caenorhabditis elegans, as a rapid tool to understand cellular adaptations to cold. We will focus on mechanisms altering the abundance and types of cellular messenger RNAs and proteins, as these kinds of molecules are critical for the live-or-die decision of the cell. In some disease states, like stroke, cooling can facilitate patient’s recovery. Moreover, hibernation is of interest to ageing research, as animals tend to live longer at lower temperatures. Thus, understanding how cells adapt to cold has the potential to influence treatments of human disorders.
Aim:
As a Ph.D. student, you will use the powerful genetic model of Caenorhabditis elegans, which can display a hibernation-like behavior, to determine the mechanism and role of the UCS domain-containing proteins and co-working chaperones in the regulation of cross-talk between translation and proteostasis in the cold. To develop the preliminary results, you will use, e.g., polysome profiling, tissue-specific ribosome imaging, RNA sequencing, in vitro assays on purified proteins, and more.
Requirements:
-
Holds a master’s degree in biology, biochemistry or related field
-
Solid knowledge of the principles of cell and molecular biology, genetics, and/or biochemistry
-
Hands-on experience in laboratory work and familiarity with basic molecular biology techniques
-
Keen interest in translation and proteostasis regulation
-
Prior experience or knowledge of C. elegans or similar model organisms will be an advantage
-
Proficiency in written and spoken English
-
Willingness to learn and take new challenges, ability to work independently, analytical thinking
Number of positions available: 1
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
5. Title: Elucidating the epigenetic contribution to cardiovascular lineage specification (NCN/OPUS)
Supervisor: Cecilia Winata, PhD
Institute: International Institute of Molecular and Cell Biology in Warsaw
Laboratory: Laboratory of Zebrafish Developmental Genomics / Zebrafish Developmental Genomics Laboratory
Project description:
One key question in the field of organogenesis relates to how the many types of cells required to make an organ are generated from a pool of progenitor cells with initially similar characteristics. Heart (cardiac) progenitor cells are located close to those that will also generate blood and blood vessels (hemoangiogenic). At very early stages of embryonic development, they express nkx2.5 in common. Subsequently, each type of cells expresses different sets of genes and adopts epigenetic states which signifies their identity. Despite the knowledge that nkx2.5-expressing progenitors could contribute to diverse cell lineage types, several key questions remain unanswered. First, it is unclear at which developmental stage the segregation between cardiac and hemoangiogenic fates begin to occur. Second, the exact pathway and intermediate stages which these progenitors go through during the process of lineage specification are still largely unknown. In addition, despite the knowledge that cardiac transcription factors including Nkx2.5 itself are known to interact with chromatin modifying factors and promote chromatin changes, it is still unknown to what extent epigenetics play a role in driving cell fate decisions at the individual cell level. By tracing the evolution of cellular heterogeneity over time, and at the same time assessing the dynamics of epigenetic landscape at the single cell level, we will elucidate the mechanism of cardiovascular lineage specification.
Aim:
The goal of this project is to elucidate the epigenetic contribution towards the lineage decision of nkx2.5-expressing progenitors into either cardiac or hemoangiogenic lineage. We hypothesize that distinct epigenetic states occur among subpopulations of nkx2.5-expressing progenitors according to their lineage diversification potential. We will profile open chromatin regions at single cell level and determine whether Nkx2.5 plays a role in establishing the epigenetic state by scATAC-seq method (Jia et al., 2018, Nat Commun 9, 4877).
Requirements:
-
Master’s degree in Biology, Biochemistry, or related area
-
Solid understanding of the principles of molecular biology and genetics
-
Previous laboratory experience in molecular biology and/or biochemistry techniques
-
Prior experience in flow cytometry, NGS, and/or working with animal models (mouse or zebrafish), as well as basic programming skills would be an advantage although not essential
-
Ability to communicate fluently in English and has a collaborative attitude
Number of positions available: 1
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
For more information please follow:
The admissions process is conducted through the Doctoral School website system. The PhD student can apply to this specific project carried out as part of the Warsaw-4-PhD doctoral school via website https://bit.ly/3tegzul (the application system will be activated from 21st December, 2022; deadline for sending application is 4th January, 2023). For more information, please follow the link https://bit.ly/3g5tOtV
PhD Student
Title: Structural studies of herpesvirus proteins involved in DNA replication
Laboratory of Protein Structure
PhD Student
Title: RNA-Protein Interactions in Human Health and Disease (NCN/DIOSUCRI)
Laboratory of RNA-Protein Interactions – Dioscuri Centre
GENERAL RECRUITMENT INFORMATION CLAUSE
Pursuant to Article 13 (1) and (2) of Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016, on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (OJ EU L 119/1 dated 4.5.2016), hereinafter referred to as “GDPR”, we inform you that:
I. DATA ADMINISTRATOR
1. The data Administrator is the International Institute of Molecular and Cell Biology in Warsaw (hereinafter: “the Administrator”), ul. Księcia Trojdena 4, 02-109 Warsaw.
2. You may contact the Data Protection Officer appointed by the Administrator regarding the protection of your personal data at the following email address: This email address is being protected from spambots. You need JavaScript enabled to view it.
3. In the case of recruitment procedures for a job position providing for employment on the basis of an employment contract (Labor Code), the Administrator expects the provision of personal data (e.g. in a CV) only to the extent specified in the labor law regulations (Article 221 of the Labor Code). If an applicant provides other data that the Administrator does not need, it is assumed that he/she has given an implied consent to their processing, which may be withdrawn at any time without affecting the lawfulness of the processing carried out before the withdrawal.
4. If a job applicant voluntarily provides special categories of data in their application documents, such as information on their health status or disability, an explicit consent is required for the processing of these personal data in accordance with Article 9(2)(a) of the GDPR.
5. In the case of application for a job position at which relevant laws require the provision of information on lack of criminal records, the exercise of full public rights or the determination of qualifications for a particular job, the Administrator may require the provision of such data in accordance with the applicable legal provisions (Article 6(1)(10) of the National Criminal Records Act).
6. The provision of data to the extent specified in the Labor Code or other specific laws (in accordance with the requirements of the job advertisement) is necessary for participation in the recruitment process. Failure to provide these data may result in the exclusion of the applicant from the current recruitment process. The provision of other data is voluntary and has no effect on the possibility of participating in the recruitment process, with the exception of special categories of data (see point 4 above).
II. PURPOSES AND BASES OF PROCESSING OF PERSONAL DATA
1. The data collected as a part of the recruitment process have been obtained directly from you and are processed:
a) to fulfill legal obligations related to the employment process on the basis of an employment contract pursuant to Article 6(1)(c) of the GDPR - legal obligation of the Administrator under the Labor Code (Article 221 of the Labor Code), or
b) to fulfil legal obligations related to the employment process on the basis of a civil law contract pursuant to Article 6(1)(b) of the GDPR - conclusion of a contract and taking measures at the request of the data subject prior to the conclusion of the contract, and
c) to assert or pursue possible claims or to defend against such claims on the basis of Administrator's legitimate interest pursuant to Article 6(1)(f) of the GDPR, e.g. to defend Administrator's rights in connection with possible allegations of unequal treatment during the employment process,
d) in the case of additional implied consent based on Article 6(1)(a) of the GDPR (consent) to carry out the recruitment process in relation to data that is not required by law (e.g. image) or to express the will to participate in future recruitment processes of the Administrator and Article 9(2)(a) of the GDPR (explicit (written) consent to the processing of special categories of personal data), e.g. voluntarily provided information about a disability.
2. An example of the content of written consents that the job applicant should include in their application documents depending on the purpose chosen:
a) in case of expressing interest in the future recruitment processes:
"I consent to the processing of my personal data provided in the submitted application documents by the International Institute of Molecular and Cell Biology in Warsaw, ul. Księcia Trojdena 4, 02-109 Warsaw, for the purpose of participation in future recruitment processes of the Administrator."
b) if the applicant provides data revealing their racial or ethnic origin, political opinions, religious or philosophical beliefs, trade union membership, genetic data, biometric data, data concerning health or data concerning sexual orientation in accordance with Article 9(1) of the GDPR (sensitive data):
"I consent to the processing of my special categories of personal data referred to in Article 9(1) of the GDPR contained in the submitted application documents by the International Institute of Molecular and Cell Biology in Warsaw, ul. Księcia Trojdena 4, 02-109 Warsaw, for the purpose of participating in the recruitment process conducted by the Administrator."
III. RECIPIENTS OF PERSONAL DATA
- Personal data may be disclosed to Administrator’s employees or collaborators and to entities that support the Administrator under data processing agreements (pursuant to Article 28 of the GDPR), including, but not limited to, website providers, software providers, providers of electronic services (email, cloud services, internet messengers) used by the Administrator, auditing firms, consulting firms, and other entities that collaborate with the Administrator.
- In connection with the conduct of scientific activities, personal data may be disclosed to external entities, including, in particular, the entities that may provide the Administrator with information about candidate's diploma issued by a foreign university, as well as his/her level of study and university status - (in accordance with Article 326(4) of the Law on Higher Education and Science) or the entities cooperating with the Administrator in the implementation of research projects, if the interested person is involved in such a project, in particular:
- in the case of Projects funded by the National Science Centre, the recipient of the data will be the National Science Centre in Cracow with its seat at ul. Twardowskiego 16, 30-312 Cracow, Tax Identification Number: 676-242-96-38,
- in the case of Projects funded by the Polish National Agency for Academic Exchange, the recipient of the data will be the Polish National Agency for Academic Exchange, with its seat at ul. Polna 40, 00-635 Warsaw, Tax Identification Number: 5272820369,
- in the case of Projects financed by the Foundation for Polish Science, the recipient of the data will be the Foundation for Polish Science with its seat at ul. I. Krasickiego 20/22, 02-611 Warsaw, Tax Identification Number: 5260311952,
- in the case of Projects financed by the National Centre for Research and Development, the recipient of the data will be the National Centre for Research and Development with its seat at ul. Nowogrodzka 47a, 00-695 Warsaw, Tax Identification Number: 7010073777,
- in the case of Projects funded by the Ministry of Science and Higher Education, the recipient of the data will be the Ministry of Science and Higher Education with its seat at ul. Wspólna 1/3, 00-529 Warsaw, Tax Identification Number: 7011010460.
Recipients of personal data may also be foreign funding agencies, as well as other agencies, institutions or entities that may be a source of funding. The mentioned institutions will be indicated each time in the employment contract.
- The Administrator does not transfer data outside the EEA.
IV. PERIOD OF DATA STORAGE AND PROCESSING
1. Personal data will be processed for the period necessary to achieve the purposes described above, i.e.:
a) until the completion of the recruitment process for the specified position,
b) in case of the consent to data process for the future recruitment processes carried out by the Administrator, until the consent is withdrawn, but no longer than 6 months after the end of the respective recruitment process,
c) each time after the end of the recruitment process for the duration of the limitation period for civil law claims in order to enable the defense against possible claims or the pursuit of claims if there is a risk that such claims will be brought by or against the Administrator, for a maximum period of 3 years after the end of the recruitment process.
2. The data may only be processed for a longer period for archiving purposes in the public interest, scientific or historical research purposes or statistical purposes in accordance with Article 89(1) if it is likely that the erasure of the data would render impossible or seriously impair the achievement of the purposes of that processing.
V. RIGHTS IN RELATION TO PERSONAL DATA
You have the following rights in connection with the processing of your personal data:
a) the right of access to personal data;
b) the right to rectify personal data;
c) the right to request the deletion of personal data (unless certain regulations oblige the Administrator to keep the data);
d) the right to restrict the processing of personal data;
e) the right to data portability (in case of processing based on a contract or consent, if the processing is automated)
f) the right to object to the processing of personal data (on the basis of Article 6(1)(e) or (f), including profiling)
g) the right not to be the subject to a decision based solely on automated processing - the Administrator states that it does not process data on the basis of automated decision-making;
h) if the processing of personal data is based on your consent, you have the right to withdraw your consent at any time without affecting the lawfulness of processing based on consent before its withdrawal;
i) in case of unlawful processing of personal data, you have the right to make a complaint with the national supervisory authority for data protection, i.e. the President of the Personal Data Protection Office (ul. Stawki 2, 00-193 Warsaw).
The case study of an undescribed disease of the nervous system - modeling of human diseases in the nematode C.elegans" was the title of the speech given by Dr. Wojciech Pokrzywa, Head of the Protein Metabolism Laboratory of IIMCB. The lecture took place during the recent Congress of Rare Diseases on 14.10.2022 in Cracow.
The speech concerned the use of a model organism - C.elegans - in rare disease research. There were also presented the results of two projects related to ubiquitin ligase and lipid transporter mutations and the resulting disorders in the nervous system and accelerated aging.
The presentation was carried out within the framework of the project "Cellular adaptation to cold" (CellCOLD), National Science Center, GRIEG project, no. 2019/34/H/NZ3/00691, funded by the Norwegian Financial Mechanism 2014 - 2021.
Prof. Andrzej Dziembowski, the leader of HERO/WIB project and the Head of RNA Biology Laboratory - ERA Chairs Group has recently given an interview for Biotechnologia.pl, in which he talks about the goals of the HERO/WIB project, the advantages of precision therapies in oncology, the challenges of personalized medicine and the most innovative directions for the biotechnology and pharmaceutical industry. We highly rocommend watching it! The interview is under the LINK
-
September 1, 2022: Representatives of five Polish Dioscuri Centers at a meeting at the Max Planck Society
-
June 29, 2022: The Michlewski team discovers a new mechanism involved in TRIM25's antiviral activity
-
October 7,2021: Visit of the German delegation at the IIMCB
-
October 1, 2021: The Laboratory of RNA-Protein Interactions - Dioscuri Centre at IIMCB officially opened
-
September 22, 2021: Opening of the Laboratory of RNA-Protein Interactions - Dioscuri Centre
-
May 12, 2021: The professorial appointment for Gracjan Michlewski
-
January 18, 2021: The Dioscuri Centre for RNA - Protein Interactions in Human Health and Disease, has started
-
September 30, 2020: Dr hab. Gracjan Michlewski among the laureates of Polish Returns Programme
-
1.09.2022: Przedstawiciele pięciu polskich ośrodków Dioscuri na spotkaniu w stowarzyszeniu Maxa Plancka
-
29.07.2022: .Zespół Prof. Michlewskiego odkrył nowy mechanizm zaangażowany w aktywność przeciwwirusową białka TRIM25
-
7.10.2021: Wizyta niemieckiej delegacji w MIBMiK
-
1.10.2021: Laboratorium Oddziaływań RNA-Białko - Centrum Dioscuri w MIBMiK oficjalnie otwarte
-
22.09.2021: Uroczyste otwarcie Laboratorium Oddziaływań RNA-Białko - Centrum Dioscuri
-
12.05.2021: Nominacja profesorska dla Gracjana Michlewskiego
-
18.01.2021: Rozpoczęcie działalności przez Centrum Dioscuri
-
30.09.2020: Dr hab. Gracjan Michlewski laureatem programu NAWA Polskie Powroty